Literature DB >> 27463334

Spare Adenosine A2a Receptors Are Associated With Positive Exercise Stress Test In Coronary Artery Disease.

Jean Ruf1,2, Franck Paganelli3, Laurent Bonello3, Nathalie Kipson4, Giovanna Mottola4, Julien Fromonot4,5, Jocelyne Condo4, Alain Boussuges4, Laurie Bruzzese4, Françis Kerbaul6, Yves Jammes4, Vlad Gariboldi7, Frédéric Franceschi4, Emmanuel Fenouillet4,8, Régis Guieu4,3.   

Abstract

During exercise, cardiac oxygen-consumption increases and the resulting low oxygen level in myocardium triggers coronary vasodilation. This response to hypoxia is controlled notably by the vasodilator adenosine and its A2A receptor (A2AR). According to the "spare receptor" pharmacological model, a strong A2AR-mediated response can occur in the context of a large number of receptors remaining unoccupied, activation of only a weak fraction of A2AR (evaluated using KD) resulting in maximal cAMP production (evaluated using EC50), and hence in maximal coronary vasodilation. In coronary artery disease (CAD), myocardial ischemia limits adaptation to exercise, which is commonly detected using the exercise stress test (EST). We hypothesized that spare A2AR are present in CAD patients to correct ischemia. Seventeen patients with angiographically-documented CAD and 17 control subjects were studied. We addressed adenosine-plasma concentration and A2AR-expression at the mononuclear cell-surface, which reflects cardiovascular expression. The presence of spare A2AR was tested using an innovative pharmacological approach based on a homemade monoclonal antibody with agonist properties. EST was positive in 82% of patients, and in none of the controls. Adenosine plasma-concentration increased by 60% at peak exercise in patients only (p<0.01). Most patients (65%), and none of the controls, had spare A2AR (identified when EC50/KD≤0.1) and a low A2AR-expression (mean: -37% vs controls; p<0.01). All patients with spare A2AR had a positive EST whereas the subjects without spare A2AR had a negative EST (p<0.05). Spare A2AR are therefore associated with positive EST in CAD patients and their detection may be used as a diagnostic marker.

Entities:  

Keywords:  adenosine; cardiovascular disease; coronary artery disease; ischemia; receptor

Year:  2016        PMID: 27463334      PMCID: PMC5082304          DOI: 10.2119/molmed.2016.00052

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  25 in total

Review 1.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.

Authors:  J C Shryock; L Belardinelli
Journal:  Am J Cardiol       Date:  1997-06-19       Impact factor: 2.778

2.  Role of endogenous adenosine as a modulator of syncope induced during tilt testing.

Authors:  Alain Y Saadjian; Samuel Lévy; Fréderic Franceschi; Ibrahim Zouher; Franck Paganelli; Régis P Guieu
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

Review 3.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

4.  Adenosine and Clinical Forms of Neurally-Mediated Syncope.

Authors:  Regis Guieu; Jean-Claude Deharo; Jean Ruf; Giovanna Mottola; Nathalie Kipson; Laurie Bruzzese; Victoria Gerolami; Frederic Franceschi; Andrea Ungar; Marco Tomaino; Matteo Iori; Michele Brignole
Journal:  J Am Coll Cardiol       Date:  2015-07-14       Impact factor: 24.094

5.  KV 7 channels are involved in hypoxia-induced vasodilatation of porcine coronary arteries.

Authors:  E R Hedegaard; B D Nielsen; A Kun; A D Hughes; C Krøigaard; S Mogensen; V V Matchkov; O Fröbert; U Simonsen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Adenosine receptor-mediated coronary artery relaxation and cyclic nucleotide production.

Authors:  D J Cushing; G L Brown; M H Sabouni; S J Mustafa
Journal:  Am J Physiol       Date:  1991-08

7.  Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells.

Authors:  T Iwamoto; S Umemura; Y Toya; T Uchibori; K Kogi; N Takagi; M Ishii
Journal:  Biochem Biophys Res Commun       Date:  1994-03-15       Impact factor: 3.575

8.  Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.

Authors:  M McKinney; D Anderson; L Vella-Rountree
Journal:  Mol Pharmacol       Date:  1989-01       Impact factor: 4.436

Review 9.  Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic review and meta-analysis of prospective studies.

Authors:  A Banerjee; D R Newman; A Van den Bruel; C Heneghan
Journal:  Int J Clin Pract       Date:  2012-05       Impact factor: 2.503

10.  Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia.

Authors:  Tobias Eckle; Katherine Hartmann; Stephanie Bonney; Susan Reithel; Michel Mittelbronn; Lori A Walker; Brian D Lowes; Jun Han; Christoph H Borchers; Peter M Buttrick; Douglas J Kominsky; Sean P Colgan; Holger K Eltzschig
Journal:  Nat Med       Date:  2012-04-15       Impact factor: 53.440

View more
  10 in total

1.  Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.

Authors:  Mélanie Gaubert; Marion Marlinge; Marine Alessandrini; Marc Laine; Laurent Bonello; Julien Fromonot; Jennifer Cautela; Franck Thuny; Jeremie Barraud; Giovanna Mottola; Pascal Rossi; Emmanuel Fenouillet; Jean Ruf; Régis Guieu; Franck Paganelli
Journal:  Purinergic Signal       Date:  2018-04-06       Impact factor: 3.765

2.  Adaptative mechanism of the equilibrative nucleoside transporter 1 (ENT-1) and blood adenosine levels in elite freedivers.

Authors:  M Marlinge; D Vairo; R Guieu; F Joulia; A Bertaud; C Vernet; M Chefrour; L Bruzzese; M C Chaptal; G Mottola; A Boussuges; J J Risso; M Blot-Chabaud; M Coulange
Journal:  Eur J Appl Physiol       Date:  2020-10-14       Impact factor: 3.078

3.  Specific Pharmacological Profile of A2A Adenosine Receptor Predicts Reduced Fractional Flow Reserve in Patients With Suspected Coronary Artery Disease.

Authors:  Franck Paganelli; Noémie Resseguier; Marion Marlinge; Marc Laine; Fabrice Malergue; Nathalie Kipson; Pauline Armangau; Nicolas Pezzoli; Francois Kerbaul; Laurent Bonello; Giovanna Mottola; Emmanuel Fenouillet; Régis Guieu; Jean Ruf
Journal:  J Am Heart Assoc       Date:  2018-04-13       Impact factor: 5.501

Review 4.  Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases.

Authors:  Marine Gaudry; Donato Vairo; Marion Marlinge; Melanie Gaubert; Claire Guiol; Giovanna Mottola; Vlad Gariboldi; Pierre Deharo; Stéphane Sadrin; Jean Michel Maixent; Emmanuel Fenouillet; Jean Ruf; Regis Guieu; Franck Paganelli
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

5.  Homocysteine concentration and adenosine A2A receptor production by peripheral blood mononuclear cells in coronary artery disease patients.

Authors:  Pierre Deharo; Marion Marlinge; Clair Guiol; Donato Vairo; Julien Fromonot; Patrick Mace; Mohamed Chefrour; Marguerite Gastaldi; Laurie Bruzzese; Melanie Gaubert; Marine Gaudry; Nathalie Kipson; Christine Criado; Thomas Cuisset; Franck Paganelli; Jean Ruf; Regis Guieu; Emmanuel Fenouillet; Giovanna Mottola
Journal:  J Cell Mol Med       Date:  2020-06-29       Impact factor: 5.310

6.  Extracellular vesicles with ubiquitinated adenosine A2A receptor in plasma of patients with coronary artery disease.

Authors:  Jean Ruf; Donato Vairo; Franck Paganelli; Régis Guieu
Journal:  J Cell Mol Med       Date:  2019-08-24       Impact factor: 5.310

Review 7.  Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?

Authors:  Franck Paganelli; Giovanna Mottola; Julien Fromonot; Marion Marlinge; Pierre Deharo; Régis Guieu; Jean Ruf
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

8.  Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT1A Serotonin Receptor Antagonists.

Authors:  Kinga Ostrowska; Anna Leśniak; Zuzanna Czarnocka; Jagoda Chmiel; Magdalena Bujalska-Zadrożny; Bartosz Trzaskowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-24

9.  Plasma A2AR Measurement Can Help Physicians Identify Patients Suspected of Coronary Chronic Syndrome: A Pilot Study.

Authors:  Franck Paganelli; Gabriel Cappiello; Soumeya Aliouane; Nathalie Kipson; Christine Criado; Khadidja Hamou; Jehuel Ntawanga; Erika Peroni; Maria Carreno; Lucas Methlin; Giovanna Mottola; Julien Fromonot; Pierre Deharo; Marine Gaudry; Marion Marlinge; Régis Guieu; Jean Ruf
Journal:  Biomedicines       Date:  2022-08-01

Review 10.  Adenosine Receptor Profiling Reveals an Association between the Presence of Spare Receptors and Cardiovascular Disorders.

Authors:  Emmanuel Fenouillet; Giovanna Mottola; Nathalie Kipson; Franck Paganelli; Régis Guieu; Jean Ruf
Journal:  Int J Mol Sci       Date:  2019-11-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.